Amoxicillin Injection - Shijiazhuang Shimu Pharmaceutical Co., Ltd.|Veterinary Antibiotic Solution

Amoxicillin Injection is a critical pharmaceutical solution designed for veterinary use, offering broad-spectrum antibacterial activity against both gram-positive and gram-negative pathogens. This article provides an in-depth analysis of its pharmacokinetic properties, clinical applications, technical specifications, and the reputable company behind its production, Shijiazhuang Shimu Pharmaceutical Co., Ltd..

Product Overview

Amoxicillin Injection is a semisynthetic penicillin antibiotic formulated for intramuscular administration in livestock. It is specifically indicated for treating respiratory infections caused by Mannheimia haemolytica and Pasteurella multocida in cattle and pigs. The product's efficacy is rooted in its ability to inhibit bacterial cell wall synthesis, making it a cornerstone in veterinary medicine.

Pharmacokinetic Properties

The pharmacokinetic profile of Amoxicillin Injection is critical to its therapeutic success. In cattle, the maximum plasma concentration (Cmax) of 3.45 µg/ml is achieved 2.45 hours post-administration, while pigs reach a Cmax of 3.54 µg/ml within 2 hours. This rapid absorption ensures effective drug levels at the infection site.

Amoxicillin's low plasma protein binding (17%) facilitates its distribution into extracellular compartments, including pulmonary, pleural, and bronchial tissues. Its ability to diffuse into pleural, synovial, and lymphatic fluids enhances its capacity to combat infections in these critical areas.

Metabolism occurs primarily in the liver via hydrolysis of the β-lactam ring, resulting in the formation of inactive penicilloic acid (20%). Excretion is predominantly renal, with secondary pathways through the biliary tract and milk, necessitating adherence to withdrawal periods for food safety.

Clinical Applications and Efficacy

Amoxicillin Injection is a vital tool in veterinary medicine for managing bacterial infections in livestock. Its broad-spectrum activity against both gram-positive and gram-negative bacteria makes it suitable for respiratory conditions such as pneumonia and bronchitis. The drug's time-dependent mechanism of action ensures sustained bacterial inhibition, reducing the risk of resistance development.

Key applications include:

• Treatment of respiratory tract infections in cattle and pigs
• Management of bacterial infections caused by Mannheimia haemolytica and Pasteurella multocida
• Supportive therapy in cases of mixed bacterial infections

Advantages and Safety Profile

One of the primary advantages of Amoxicillin Injection is its favorable safety profile when used as directed. However, hypersensitivity reactions, including allergic responses, may occur in animals with a known beta-lactam allergy. Local injection site reactions are rare but transient.

The product's withdrawal periods are strictly regulated to ensure food safety. For cattle and pigs, the withdrawal period is 28 days, while milk must be discarded for 4 hours post-treatment. These measures align with global standards for veterinary drug residues, as emphasized by the National Institute of Standards and Technology (NIST), which plays a pivotal role in developing measurement standards for pharmaceutical safety.

Technical Specifications

Parameter	Details
Active Ingredient	Amoxicillin 150 mg/ml
Administration Route	Intramuscular
Concentration	150 mg per mL
Storage Conditions	Sealed, protected from light, and out of reach of children
Shelf Life	3 years
Packaging	100 ml/bottle
Withdrawal Period	28 days (cattle/pigs), 4 hours (milk)

Company Background: Shijiazhuang Shimu Pharmaceutical Co., Ltd.

Shijiazhuang Shimu Pharmaceutical Co., Ltd. is a leading manufacturer of veterinary pharmaceuticals, renowned for its commitment to quality and innovation. Based in China, the company adheres to stringent regulatory standards to ensure the safety and efficacy of its products. Their expertise in antibiotic formulation is evident in the precision of Amoxicillin Injection, which is designed to meet the specific needs of livestock health management.

Shijiazhuang Shimu Pharmaceutical Co., Ltd. emphasizes research and development, leveraging advanced technologies to improve drug delivery systems. Their dedication to compliance with international standards positions them as a trusted partner in the veterinary pharmaceutical industry.

Conclusion

Amoxicillin Injection is a vital therapeutic option for treating bacterial infections in cattle and pigs. Its robust pharmacokinetic profile, broad-spectrum activity, and adherence to safety protocols make it an essential tool for veterinarians. Manufactured by Shijiazhuang Shimu Pharmaceutical Co., Ltd., the product exemplifies the intersection of scientific innovation and regulatory excellence in veterinary medicine.

References

National Institute of Standards and Technology (NIST). (n.d.). Standards and Measurements. Retrieved from https://www.nist.gov

Shijiazhuang Shimu Pharmaceutical Co., Ltd.. (n.d.). Product Specifications. Retrieved from https://www.skyvetpharm.com

Amoxicillin Injection. (n.d.). Product Information. Retrieved from https://www.skyvetpharm.com/amoxicillin-injection.html